| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | EPIZYME INC COM | 250,000 | 6,000,000 | 1.94% | ||
| 52 | CIGNA CORPORATION | 37,500 | 6,075,000 | 1.97% | ||
| 53 | DEPHEID | 100,000 | 6,115,000 | 1.98% | ||
| 54 | Esperion Therapeutics Inc | 75,000 | 6,132,000 | 1.99% | ||
| 55 | NANOSTRING TECHNOLOGIES INC | 400,000 | 6,168,000 | 2.00% | ||
| 56 | GENMARK DIAGNOSTICS INC. | 750,000 | 6,795,000 | 2.20% | ||
| 57 | HORIZON PHARMA PLC | 200,000 | 6,948,000 | 2.25% | ||
| 58 | VERTEX PHARMACEUTICALS INC | 60,000 | 7,409,000 | 2.40% | ||
| 59 | PORTOLA PHARMACEUTICALS INC | 170,000 | 7,744,000 | 2.51% | ||
| 60 | ALEXION PHARMACEUTIC | 50,000 | 9,039,000 | 2.93% | ||
| 61 | GW PHARMACEUTICALS PLC | 75,000 | 9,213,000 | 2.99% | ||
| 62 | ENDO INTL PLC | 120,000 | 9,558,000 | 3.10% | ||
| 63 | INTUITIVE SURGICAL INC | 20,000 | 9,690,000 | 3.14% | ||
| 64 | FIVE PRIME THERAPEUTICS INC | 425,000 | 10,557,000 | 3.42% | ||
| 65 | ALNYLAM PHARMACEUTICALS INC | 90,000 | 10,788,000 | 3.50% | ||
| 66 | NUVASIVE INC | 235,000 | 11,134,000 | 3.61% | ||
| 67 | BIOGEN INC | 30,000 | 12,118,000 | 3.93% | ||
| 68 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 575,000 | 12,184,000 | 3.95% | ||
| 69 | ALLERGAN PLC | 45,000 | 13,656,000 | 4.43% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-034669, filed 2015.09.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
